$AGRX I have a mixed feeling for this stock. I was all in two weeks ago and lost a pay check when the FDA approval was extended. Now I see that this is back to where it was, but one thing really concerns me is that why would FDA extend it did 3 months if the data provide was good. Is the Adcom vote 14:1 that’s driving this stock then I would suggest to be careful.
  • 3
  • 10